newsfilter
← Latest News
GlobeNewswire·

Small Pharma Announces Positive Six-month Data from Phase IIa Trial of SPL026

LONDON, April 04, 2023 (GLOBE NEWSWIRE) -- Small Pharma Inc. (TSXV:DMT) (OTCQB:DMTTF) (the "Company" or "Small Pharma"), a biotechnology company focused on short-duration psychedelic-assisted therapies for mental